PT350 – Jim Gilligan – Psilocybin and Accessing the “Off” Switch For Nociplastic Pain

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.  www.psychedelicstoday.com